Trial intelligence / Profile preview

Synflorix Booster and Catch-up Study in Children

NCT00513409Phase 2Completed

Sponsor
GSK
Start
Aug 2007
Primary completion
Feb 2008
Modality
Split/Subunit Vaccines
Countries
1
01

Overview

A Phase 2 trial of 10-valent pneumococcal conjugate vaccine in pneumococcal infection, sponsored by GSK. Started Aug 2007; status: completed.

02

Drugs

10-valent pneumococcal conjugate vaccine
03

Conditions

pneumococcal infection

Beyond the preview

Go deeper on NCT00513409.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00513409.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call